Search for Clinical Trial Results

Sponsored By

Prurigo Nodularis - 7 Studies Found

Status Study
Completed Study Name: A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
Condition: Prurigo Nodularis
Date: 2014-07-14
Interventions:
  • Drug: serlopitant NK1 receptor
Completed Study Name: Safety and Efficacy of CC-10004 for Prurigo Nodularis
Condition: Prurigo Nodularis
Date: 2009-03-23
Interventions: Drug: CC-10004 30mg,oral medication, BID, for 24 weeks (60mg total DAILY)
Completed Study Name: Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
Condition: Prurigo Nodularis
Date: 2007-09-19
Interventions: Drug: citalopram (cipralex) 10-20 mg/day, for 12 weeks.
Active, not recruiting Study Name: Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Condition:
  • Prurigo Nodularis
  • Nodularis Prurigo
  • Drug: nalbuphine HCl ER 90 mg BID

Completed Study Name: Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
Condition: Prurigo Nodularis
Date: 2007-07-26
Interventions:
  • Drug: Pimecrolimus twice daily
Completed Study Name: Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Condition:
  • Prurigo Nodularis
  • Nodularis Prurigo
  • Drug: nalbuphine HCl ER tablets 90 mg BID

Not yet recruiting Study Name: Dapsone Prurigo Study
Condition: Lichen Simples Chronicus and Prurigo
Date: 2013-06-03
Interventions: Drug: Dapsone gel - verum Other Name: aczone gel